|
J1-1709
|
Structural insight into the mechanism of Clostridium difficile surface formation
|
1.7.2019 - 30.6.2023
|
IJS dr. Dušan Turk
FFA dr. Janez Mravljak
|
|
J1-1717
|
Development of novel Hsp90 inhibitors with anticancer activity
|
1.7.2019 - 30.6.2023
|
Tihomir Tomašič
|
|
J1-2483
|
Radiopharmaceuticals with antagonistic activity on CCK2R
|
1.9.2020 - 31.8.2023
|
Marko Anderluh
|
|
J1-2484
|
Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis
|
1.9.2020 - 31.8.2023
|
Stanislav Gobec
|
|
J1-2485
|
The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs
|
1.9.2020 - 31.8.2023
|
Izidor Sosič
|
|
J1-3018
|
Smart probes for ex vivo assay-based early prediction of Alzheimer disease
|
1.10.2021 - 30.9.2024
|
UL FKKT Janez Košmrlj
UL FFA Stanislav Gobec
|
|
J1-3021
|
A synthetic biofilm-based platform for studying and development of new antibiofilm strategies
|
1.10.2021 - 30.9.2024
|
UL BF Iztok Dogša
UL FFA Nace Zidar
|
|
J1-3030
|
MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance
|
1.10.2021 - 30.9.2024
|
Lucija Peterlin Mašič
|
|
J1-3031
|
Development of new inhibitors of bacterial topoisomerases to overcome antimicrobial resistance |
1.10.2021 - 30.9.2024
|
Nace Zidar
|
|
J1-4400
|
Evaluation of transient protein states
|
1.10.2022 - 30.9.2025
|
KI Simona Golič Grdadolnik
FFA Stanislav Gobec
|
|
J1-4402
|
Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors
|
1.10.2022 - 30.9.2025
|
KI Andrej Perdih
UL FFA Marija Sollner Dolenc
|
|
J1-4414
|
ProBiS-Fold approach for binding site detection for whole structural human proteome in drug discovery
|
1.10.2022 - 30.9.2025
|
UP FAMNIT Dušanka Janežič
UL FFA Stanislav Gobec
|
|
J1-4417
|
Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy
|
1.10.2022 - 30.9.2025
|
Matej Sova
|
|
J2-3043
|
Exploitation of the magneto-mechanical effect in the treatment of neurodegenerative diseases
|
1.10.2021 - 30.9.2024
|
IJS Slavko Kralj
UL FFA Petra Kocbek
|
|
J2-4480
|
Removal of selected antimicrobials by plasma-cavitation technology from water matrices of varying complexities (Causma)
|
1.10.2022 - 30.9.2025
|
FS Martin Petkovšek
FFA Jurij Trontelj
|
|
J3-1745
|
Elucidating the role of immunoproteasome in platelet-driven immune response
|
1.7.2019 - 30.6.2023
|
Martina Gobec
|
|
J3-1749
|
Mesenchymal stem cells-the keepers of tissue endogenous regenerative capacity facing up to aging of the musculoskeletal system
|
1.7.2019 - 30.6.2023
|
Janja Zupan
|
|
J3-2517
|
Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants
|
1.9.2020 - 31.8.2023
|
Žiga Jakopin
|
|
J3-2518
|
Role of APOBEC proteins in the oncogenesis of HPV viruses
|
1.9.2020 - 31.8.2023
|
UNG Martina Bergant Marušič
UL FFA Marija Nika Lovšin
|
|
J3-2521
|
Inflammatory process in interstitial cystitis and evaluation of the influence of cannabinoid receptor agonists in urinary bladder - from cells to patients
|
1.9.2020 - 31.8.2023
|
UL MF Peter Veranič
FFA Mojca Kerec Kos
|
|
J3-3062
|
Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer
|
1.10.2021 - 30.9.2024
|
Matjaž Jeras
|
|
J3-3071
|
Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy
|
1.10.2021 - 30.9.2024
|
IJS Ana Mitrović
UL FFA Janko Kos
|
|
J3-3079
|
Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms
|
1.12.2021 - 30.11.2024
|
Stane Pajk
|
|
J3-4496
|
Next-generation adjuvants for mucosal vaccines
|
1.10.2022 - 30.9.2025
|
Žiga Jakopin
|
|
J3-4499
|
Mechanisms of response to interleukin 12/23 blockers in ulcerative colitis - toward personalized medicine
|
1.10.2022 - 30.9.2025
|
UKC David Drobne
UL FFA Iztok Grabnar
|
|
J3-4527
|
Muscle cell secretom and bone cells interplay in osteosarcopenia (MiKOSA)
|
1.10.2022 - 30.9.2025
|
Janja Marc
|
|
J4-3092
|
Development of biologically active and chemically stable xanthophylls based on a sustainable esterification of xanthophylls from renewable natural resources
|
1.10.2021 - 30.9.2024
|
KI Alen Albreht
UL FFA Ilija German Ilić
|
|
J4-3096
|
Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile
|
1.10.2021 - 30.9.2024
|
Borut Štrukelj
|
|
J4-4556
|
New biofertilization approach based on the microbial multispecies biocatalytic aggregates
|
1.10.2022 - 30.9.2025
|
IJS Tomaž Rijavec
UL FFA Špela Zupančič
|
|
J7-2603
|
Efficacy of bacteriophages for treatment of extracellular and intracelular bacterial infections of implantants
|
1.9.2020 - 31.8.2023
|
UL FKKT Aleš Podgornik
UL FFA Janja Zupan
|
|
J7-4418
|
Nanofibers for codelivery of selected microbiota cocktails and antimicrobials for local treatment of vaginal infections
|
1.10.2022 - 30.9.2025
|
Špela Zupančič
|
|
J7-4420
|
Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles
|
1.10.2022 - 30.9.2025
|
IJS Aleš Berlec
UL FFA Marko Anderluh
|
|
J7-4635
|
MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy
|
1.10.2022 - 30.9.2025
|
Lucija Peterlin Mašič
|
|
L1-3160
|
Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration
|
1.10.2021 - 30.9.2024
|
Iztok Grabnar
|
|
L2-4455
|
Quantitative light scattering spectroscopy as a process analytical technology in pharmaceutical manufacturing
|
1.10.2022 - 30.9.2025
|
FKKT Franjo Pernuš
UL FFA Rok Dreu
|
|
L3-3176
|
The Role and Potential Application of Immunomodulatory Mesenchymal Stem Cells in COVID- 19 Disease |
1.10.2021 - 30.9.2024
|
Janja Zupan
|
|
L3-3177
|
Safety evaluation of cannabidiols and implications for public health and consumers behaviour
|
1.10.2021 - 30.9.2024
|
NIB Metka Filipič
UL FFA Jurij Trontelj
|
| L4-4564 |
Biotechnological potential of selected microorganisms from Sečovlje Saltpans for application in cosmetics products |
1.10.2022 - 30.9.2025 |
NIB Ana Rotter
UL FFA Alenka Zvonar Pobirk |
N1-0169 |
A covalent approach against antibiotic resistance |
1.1.2021 - 31.12.2023 |
Stanislav Gobec |
| N1-0172 |
Photochemistry toolbox for discovery of advanced ATP-competitive chemical probes with Topoisomerase IIalpha inhibitory activity |
1.1.2021 - 31.12.2023 |
Janez Ilaš |
| Z1-4405 |
Development of new antibiotics simultaneously targeting beta-lactamases and penicillin-binding proteins |
1.10.2022 - 30.9.2024 |
Alen Krajnc |